Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.

about

Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.

Item

http://www.wikidata.org/entity/Q51381155

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Effects of severe spasticity t ...... patients: Long term follow-up.

@en

Effects of severe spasticity t ...... patients: Long term follow-up.

@nl

type

Item

label

Effects of severe spasticity t ...... patients: Long term follow-up.

@en

Effects of severe spasticity t ...... patients: Long term follow-up.

@nl

prefLabel

Effects of severe spasticity t ...... patients: Long term follow-up.

@en

Effects of severe spasticity t ...... patients: Long term follow-up.

@nl

P1476

Effects of severe spasticity t ...... patients: Long term follow-up.

@en

P2093

Adriana Gerini

http://www.w3.org/2001/XMLSchema#string

Giulia Stampacchia

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

A benefit-risk assessment of baclofen in severe spinal spasticity.

Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review

Successful treatment of posttraumatic hemiballismus with intrathecal baclofen therapy.

Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.

Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.

Pain associated with multiple sclerosis: systematic review and proposed classification.

Recent gains in clinical multiple sclerosis research.

Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.

Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.

P304

385-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/NRE-161329

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Mazzoleni

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27061166

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis